1. Home
  2. AFMD vs BNAI Comparison

AFMD vs BNAI Comparison

Compare AFMD & BNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • BNAI
  • Stock Information
  • Founded
  • AFMD 2000
  • BNAI 2018
  • Country
  • AFMD Germany
  • BNAI United States
  • Employees
  • AFMD N/A
  • BNAI N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • BNAI
  • Sector
  • AFMD Health Care
  • BNAI
  • Exchange
  • AFMD Nasdaq
  • BNAI NYSE
  • Market Cap
  • AFMD 14.5M
  • BNAI 15.7M
  • IPO Year
  • AFMD 2014
  • BNAI N/A
  • Fundamental
  • Price
  • AFMD $0.72
  • BNAI $0.32
  • Analyst Decision
  • AFMD Strong Buy
  • BNAI Strong Buy
  • Analyst Count
  • AFMD 5
  • BNAI 1
  • Target Price
  • AFMD $13.50
  • BNAI $6.00
  • AVG Volume (30 Days)
  • AFMD 86.2K
  • BNAI 371.0K
  • Earning Date
  • AFMD 04-08-2025
  • BNAI 05-25-2025
  • Dividend Yield
  • AFMD N/A
  • BNAI N/A
  • EPS Growth
  • AFMD N/A
  • BNAI N/A
  • EPS
  • AFMD N/A
  • BNAI N/A
  • Revenue
  • AFMD $6,287,085.00
  • BNAI $99,790.00
  • Revenue This Year
  • AFMD N/A
  • BNAI $189.69
  • Revenue Next Year
  • AFMD $225.65
  • BNAI $2,400.00
  • P/E Ratio
  • AFMD N/A
  • BNAI N/A
  • Revenue Growth
  • AFMD N/A
  • BNAI 125.10
  • 52 Week Low
  • AFMD $0.70
  • BNAI $0.30
  • 52 Week High
  • AFMD $8.95
  • BNAI $8.43
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 30.95
  • BNAI 36.52
  • Support Level
  • AFMD $0.85
  • BNAI $0.33
  • Resistance Level
  • AFMD $0.89
  • BNAI $0.40
  • Average True Range (ATR)
  • AFMD 0.05
  • BNAI 0.03
  • MACD
  • AFMD -0.01
  • BNAI 0.00
  • Stochastic Oscillator
  • AFMD 22.75
  • BNAI 15.12

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About BNAI BRAND ENGAGEMENT NETWORK INC

Brand Engagement Network Inc is an innovative AI platform provider, designed to interface with emerging technologies, including blockchain, the Internet of Things, and cloud computing, that drive digital transformation across various industries and provide businesses with an unparalleled competitive edge. BEN offers a suite of configured and customizable applications, including natural language processing, anomaly detection, encryption, recommendation engines, sentiment analysis, image recognition, personalization, and real-time decision-making.

Share on Social Networks: